ArticleJournal of scleroderma and related disorders2024

Approval status of essential therapeutic drugs for systemic sclerosis versus that of drugs for rheumatoid arthritis.

Ki Won Moon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.